Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• DeSantisCELinCCMariottoABCancer treatment and survivorship statistics, 2014CA Cancer J Clin201464425227124890451
   PubMed Web of Science ®Google Scholar
• KeatingNLO’MalleyAJSmithMRDiabetes and cardiovascular disease during androgen deprivation therapy for prostate cancerJ Clin Oncol200624274448445616983113
   PubMed Web of Science ®Google Scholar
• Lu-YaoGLAlbertsenPCMooreDFSurvival following primary androgen deprivation therapy among men with localized prostate cancerJAMA2008300217318118612114
   PubMed Web of Science ®Google Scholar
• MottetNBellmuntJBollaMEAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancerEur Urol201159457258321315502
   PubMed Web of Science ®Google Scholar
• PerlmutterMALeporHAndrogen deprivation therapy in the treatment of advanced prostate cancerRev Urol20079Suppl 1S3S817387371
   PubMedGoogle Scholar
• SharifiNGulleyJLDahutWLAndrogen deprivation therapy for prostate cancerJAMA2005294223824416014598
   PubMed Web of Science ®Google Scholar
• SharifiNGulleyJLDahutWLAn update on androgen deprivation therapy for prostate cancerEndocr Relat Cancer2010174R305R31520861285
   PubMed Web of Science ®Google Scholar
• AhmadiHDaneshmandSAndrogen deprivation therapy: evidence-based management of side effectsBJU Int2013111454354823351025
   PubMed Web of Science ®Google Scholar
• CheungASZajacJDGrossmannMMuscle and bone effects of androgen deprivation therapy: current and emerging therapiesEndocr Relat Cancer2014215R371R39425056176
   PubMed Web of Science ®Google Scholar
• NguyenPLAlibhaiSMBasariaSAdverse effects of androgen deprivation therapy and strategies to mitigate themEur Urol201567582583625097095
   PubMed Web of Science ®Google Scholar
• Van PoppelHTombalBCardiovascular risk during hormonal treatment in patients with prostate cancerCancer Manag Res20113495521448299
   PubMedGoogle Scholar
• TunnUThe current status of intermittent androgen deprivation (IAD) therapy for prostate cancer: putting IAD under the spotlightBJU Int200799Suppl 11922 discussion 23–1417229164
   PubMed Web of Science ®Google Scholar
• GrucaDBacherPTunnUSafety and tolerability of intermittent androgen deprivation therapy: a literature reviewInt J Urol201219761462522435512
   PubMed Web of Science ®Google Scholar
• GrundySMBenjaminIJBurkeGLDiabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart AssociationCirculation1999100101134114610477542
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionA Report of the Surgeon General: Physical Activity and Health1996Atlanta (GA)US Department of Health and Human Services Available from: www.cdc.gov/nccdphp/sgr/pdf/sgrfull.pdfAccessed March 3, 2016
   Google Scholar
• KenfieldSAStampferMJGiovannucciEChanJMPhysical activity and survival after prostate cancer diagnosis in the health professionals follow-up studyJ Clin Oncol201129672673221205749
   PubMed Web of Science ®Google Scholar
• MoyadMARoachM3rdPromoting wellness for patients on androgen deprivation therapy: why using numerous drugs for drug side effects should not be first-line treatmentUrol Clin North Am201138330331221798392
   PubMed Web of Science ®Google Scholar
• Demark-WahnefriedWMoreyMCSloaneRReach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivorsJ Clin Oncol201230192354236122614994
   PubMed Web of Science ®Google Scholar
• MoreyMCSnyderDCSloaneREffects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trialJAMA2009301181883189119436015
   PubMed Web of Science ®Google Scholar
• AinsworthBEHaskellWLHerrmannSD2011 Compendium of Physical Activities: a second update of codes and MET valuesMed Sci Sports Exerc20114381575158121681120
   PubMed Web of Science ®Google Scholar
• LeeIMSessoHDPaffenbargerRSJrA prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States)Cancer Courses Control2001122187193
   PubMed Web of Science ®Google Scholar
• PatelAVRodriguezCJacobsEJSolomonLThunMJCalleEERecreational physical activity and risk of prostate cancer in a large cohort of U.S. menCancer Epidemiol Biomark Prev2005141275279
   PubMed Web of Science ®Google Scholar
• GardnerJRLivingstonPMFraserSFEffects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic reviewJ Clin Oncol201432433534624344218
   PubMed Web of Science ®Google Scholar
• HansenPADechetCBPorucznikCALaStayoPCComparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot studyPM R20091111019102419942188
   PubMedGoogle Scholar
• SegalRJReidRDCourneyaKSResistance exercise in men receiving androgen deprivation therapy for prostate cancerJ Clin Oncol20032191653165912721238
   PubMed Web of Science ®Google Scholar
• BourkeLDollHCrankHDaleyARosarioDSaxtonJMLifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility studyCancer Epidemiol Biomark Prev2011204647657
   PubMed Web of Science ®Google Scholar
• GalvãoDATaaffeDRSpryNJosephDNewtonRUCombined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trialJ Clin Oncol201028234034719949016
   PubMed Web of Science ®Google Scholar
• HansonEDSheaffAKSoodSStrength training induces muscle hypertrophy and functional gains in black prostate cancer patients despite androgen deprivation therapyJ Gerontol A Biol Sci Med Sci201368449049823089339
   PubMed Web of Science ®Google Scholar
• Culos-ReedSNRobinsonJWLauHPhysical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week interventionSupport Care Cancer201018559159919609570
   PubMed Web of Science ®Google Scholar
• Santa MinaDAlibhaiSMMatthewAGA randomized trial of aerobic versus resistance exercise in prostate cancer survivorsJ Aging Phys Act201321445547823238110
   PubMed Web of Science ®Google Scholar
• Culos-ReedSNRobinsonJLLauHO’ConnorKKeatsMRBenefits of a physical activity intervention for men with prostate cancerJ Sport Exerc Psychol200729111812717556779
   PubMed Web of Science ®Google Scholar
• SegalRJReidRDCourneyaKSRandomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancerJ Clin Oncol200927334435119064985
   PubMed Web of Science ®Google Scholar
• CellaDThe Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigueSemin Hematol1997343 Suppl 213199253779
   PubMed Web of Science ®Google Scholar
• YellenSBCellaDFWebsterKBlendowskiCKaplanEMeasuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJ Pain Symptom Manage199713263749095563
   PubMed Web of Science ®Google Scholar
• CormiePNewtonRUSpryNJosephDTaaffeDRGalvaoDASafety and efficacy of resistance exercise in prostate cancer patients with bone metastasesProstate Cancer Prostatic Dis201316432833523917308
   PubMed Web of Science ®Google Scholar
• O’NeillRFHaseenFMurrayLJO’SullivanJMCantwellMMA randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancerJ Cancer Surviv20159343144025916660
   PubMed Web of Science ®Google Scholar
• CormiePGalvaoDASpryNCan supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trialBJU Int2015115225626624467669
   PubMed Web of Science ®Google Scholar
• HasenoehrlTKeilaniMSedghi KomanadjTThe effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic reviewSupport Care Cancer20152382479249726003426
   PubMed Web of Science ®Google Scholar
• KeatingNLO’MalleyAJFreedlandSJSmithMRDiabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancerJ Natl Cancer Inst20101021394619996060
   PubMed Web of Science ®Google Scholar
• FDA drug safety communication: update to ongoing safety review of GnRH agonists and notification to manufacturers of GnRH agonists to add new safety information to labeling regarding increased risk of diabetes and certain cardiovascular diseases2010Silver Spring (MD)US Food and Drug Administration Available from: http://www.fda.gov/Drugs/DrugSafety/ucm229986.htmAccessed April 29, 2016
   Google Scholar
• EfstathiouJABaeKShipleyWUCardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31J Clin Oncol2009271929919047297
   PubMed Web of Science ®Google Scholar
• BlairSNJacksonASPhysical fitness and activity as separate heart disease risk factors: a meta-analysisMed Sci Sports Exerc200133576276411323545
   PubMed Web of Science ®Google Scholar
• FagardRHExercise characteristics and the blood pressure response to dynamic physical trainingMed Sci Sports Exerc2001336 SupplS484S492 discussion S493–S49411427774
   PubMed Web of Science ®Google Scholar
• LeonASRiceTMandelSBlood lipid response to 20 weeks of supervised exercise in a large biracial population: the HERITAGE Family StudyMetabolism200049451352010778878
   PubMed Web of Science ®Google Scholar
• ThompsonPDBuchnerDPinaILExercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)Circulation2003107243109311612821592
   PubMed Web of Science ®Google Scholar
• Rafieian-KopaeiMSetorkiMDoudiMBaradaranANasriHAtherosclerosis: process, indicators, risk factors and new hopesInt J Prev Med20145892794625489440
   PubMedGoogle Scholar
• RidkerPMLDL cholesterol: controversies and future therapeutic directionsLancet2014384994360761725131980
   PubMed Web of Science ®Google Scholar
• GalvãoDASpryNATaaffeDRChanges in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancerBJU Int20081021444718336606
   PubMed Web of Science ®Google Scholar
• GreenspanSLCoatesPSereikaSMNelsonJBTrumpDLResnickNMBone loss after initiation of androgen deprivation therapy in patients with prostate cancerJ Clin Endocrinol Metab200590126410641716189261
   PubMed Web of Science ®Google Scholar
• MoroteJMorinJPOrsolaAPrevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancerUrology200769350050417382153
   PubMed Web of Science ®Google Scholar
• EbelingPRClinical practice. Osteoporosis in menN Engl J Med2008358141474148218385499
   PubMed Web of Science ®Google Scholar
• HamiltonEJGhasem-ZadehAGianattiEStructural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapyJ Clin Endocrinol Metab20109512E456E46320881261
   PubMed Web of Science ®Google Scholar
• De LaetCKanisJAOdenABody mass index as a predictor of fracture risk: a meta-analysisOsteoporos Int200516111330133815928804
   PubMed Web of Science ®Google Scholar
• GonnelliSCaffarelliCNutiRObesity and fracture riskClin Cases Miner Bone Metab201411191425002873
   PubMedGoogle Scholar
• ZhangPPetersonMSuGLWangSCVisceral adiposity is negatively associated with bone density and muscle attenuationAm J Clin Nutr2015101233734325646331
   PubMed Web of Science ®Google Scholar
• KerrDMortonADickIPrinceRExercise effects on bone mass in postmenopausal women are site-specific and load-dependentJ Bone Miner Res19961122182258822346
   PubMed Web of Science ®Google Scholar
• MaddalozzoGFSnowCMHigh intensity resistance training: effects on bone in older men and womenCalcif Tissue Int200066639940410821873
   PubMed Web of Science ®Google Scholar
• VincentKRBraithRWResistance exercise and bone turnover in elderly men and womenMed Sci Sports Exerc2002341172311782642
   PubMed Web of Science ®Google Scholar
• CarlinBIAndrioleGLThe natural history, skeletal complications, and management of bone metastases in patients with prostate carcinomaCancer20008812 Suppl2989299410898342
   PubMedGoogle Scholar
• AlibhaiSMDuong-HuaMCheungAMFracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 menJ Urol2010184391892320643458
   PubMed Web of Science ®Google Scholar
• BoberSLVarelaVSSexuality in adult cancer survivors: challenges and interventionJ Clin Oncol201230303712371923008322
   PubMed Web of Science ®Google Scholar
• NgEWooHHTurnerSLeongEJacksonMSpryNThe influence of testosterone suppression and recovery on sexual function in men with prostate cancer: observations from a prospective study in men undergoing intermittent androgen suppressionJ Urol201218762162216622503022
   PubMed Web of Science ®Google Scholar
• ResnickMJKoyamaTFanKHLong-term functional outcomes after treatment for localized prostate cancerN Engl J Med2013368543644523363497
   PubMed Web of Science ®Google Scholar
• KratzikCWLacknerJEMarkIHow much physical activity is needed to maintain erectile function? Results of the Androx Vienna Municipality StudyEur Urol200955250951618359146
   PubMed Web of Science ®Google Scholar
• CormiePNewtonRUTaaffeDRExercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trialProstate Cancer Prostatic Dis201316217017523318529
   PubMed Web of Science ®Google Scholar
• HamiltonKChambersSKLeggMOliffeJLCormiePSexuality and exercise in men undergoing androgen deprivation therapy for prostate cancerSupport Care Cancer201523113314225005233
   PubMed Web of Science ®Google Scholar
• Braga-BasariaMDobsASMullerDCMetabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapyJ Clin Oncol200624243979398316921050
   PubMed Web of Science ®Google Scholar
• AlbertiKGEckelRHGrundySMHarmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of ObesityCirculation2009120161640164519805654
   PubMed Web of Science ®Google Scholar
• NobesJPLangleySEKlopperTRussell-JonesDLaingRWA prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapyBJU Int2012109101495150221933330
   PubMed Web of Science ®Google Scholar
• MoroteJGómez-CaamañoAAlvarez-OssorioJLThe metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapyJ Urol201519361963196925541340
   PubMed Web of Science ®Google Scholar
• SmithMRFinkelsteinJSMcGovernFJChanges in body composition during androgen deprivation therapy for prostate cancerJ Clin Endocrinol Metab200287259960311836291
   PubMed Web of Science ®Google Scholar
• SmithMRLeeHMcGovernFMetabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndromeCancer2008112102188219418348297
   PubMed Web of Science ®Google Scholar
• GalvãoDASpryNDenhamJA multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAREur Urol201465585686424113319
   PubMed Web of Science ®Google Scholar
• NewtonRUTaaffeDRSpryNCan exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?BMC Cancer20121243223013489
   PubMed Web of Science ®Google Scholar
• BrownJKByersTDoyleCNutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choicesCA Cancer J Clin200353526829114570227
   PubMed Web of Science ®Google Scholar
• SchmitzKHCourneyaKSMatthewsCAmerican College of Sports Medicine roundtable on exercise guidelines for cancer survivorsMed Sci Sports Exerc20104271409142620559064
   PubMed Web of Science ®Google Scholar
• BourkeLSohanpalRNantonVCrankHRosarioDJSaxtonJMA qualitative study evaluating experiences of a lifestyle intervention in men with prostate cancer undergoing androgen suppression therapyTrials20121320823151126
   PubMed Web of Science ®Google Scholar
• HolzbeierleinJMCastleEThrasherJBComplications of androgen deprivation therapy: prevention and treatmentOncology (Williston Park)2004183303309 discussion 310, 315, 319–32115065701
   PubMed Web of Science ®Google Scholar
• MoyadMAPromoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patientsUrol Oncol2005231566415885584
   PubMed Web of Science ®Google Scholar
• SprietLLExercise and sport performance with low doses of caffeineSports Med201444Suppl 2S175S18425355191
   PubMed Web of Science ®Google Scholar
• CornishRSBolamKASkinnerTLEffect of caffeine on exercise capacity and function in prostate cancer survivorsMed Sci Sports Exerc201547346847524977700
   PubMed Web of Science ®Google Scholar
• TangBMEslickGDNowsonCSmithCBensoussanAUse of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysisLancet2007370958865766617720017
   PubMed Web of Science ®Google Scholar
• MottetNBastianPJBellmuntJGuidelines on Prostate Cancer2014European Association of Urology Available from: https://uroweb.org/.../1607-Prostate-Cancer_LRV3.pdfAccessed June 28, 2016
   Google Scholar
• Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and CalciumRossACTaylorCLYaktineALDel ValleHBDietary Reference Intakes for Calcium and Vitamin DWashington (DC)The National Academies Press2011
   Google Scholar
• CosmanFde BeurSJLeBoffMSClinician’s Guide to Prevention and Treatment of OsteoporosisOsteoporos Int201425102359238125182228
   PubMed Web of Science ®Google Scholar
• DattaMSchwartzGGCalcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical reviewOncologist20121791171117922836449
   PubMed Web of Science ®Google Scholar
• AlibhaiSMMohamedaliHZGulamhuseinHChanges in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin DOsteoporos Int201324102571257923563932
   PubMed Web of Science ®Google Scholar
• KleinSBurkeLEBrayGAClinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology FoundationCirculation2004110182952296715509809
   PubMed Web of Science ®Google Scholar
• GalvãoDATaaffeDRSpryNJosephDNewtonRUAcute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise responseJ Urol201118641291129721849187
   PubMed Web of Science ®Google Scholar
• WingRRPhysical activity in the treatment of the adulthood overweight and obesity: current evidence and research issuesMed Sci Sports Exerc19993111 SupplS547S55210593526
   PubMed Web of Science ®Google Scholar
• CermakNMResPTde GrootLCSarisWHvan LoonLJProtein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysisAm J Clin Nutr20129661454146423134885
   PubMed Web of Science ®Google Scholar
• MillerPEAlexanderDDPerezVEffects of whey protein and resistance exercise on body composition: a meta-analysis of randomized controlled trialsJ Am Coll Nutr201433216317524724774
   PubMed Web of Science ®Google Scholar
• BartonDLLiuHDakhilSRWisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2J Natl Cancer Inst2013105161230123823853057
   PubMedGoogle Scholar
• US FDA News Release P04-89FDA Announces Qualified Health Claims for Omega-3 Fatty Acids2004Silver Spring (MD)US Food and Drug Administration Available from: http://www.fda.gov/SiteIndex/ucm108351.htmAccessed March 3, 2016
   Google Scholar
• Kris-EthertonPMHarrisWSAppelLJAHA Nutrition CommitteeOmega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart AssociationArterioscler Thromb Vasc Biol200323215115212588750
   PubMed Web of Science ®Google Scholar
• OikawaSYokoyamaMOrigasaHSuppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)Atherosclerosis2009206253553919447387
   PubMed Web of Science ®Google Scholar
• YokoyamaMOrigasaHMatsuzakiMEffects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysisLancet200736995671090109817398308
   PubMed Web of Science ®Google Scholar
• GrossmannMZajacJDHematological changes during androgen deprivation therapyAsian J Androl201214218719222231300
   PubMed Web of Science ®Google Scholar
• BaileyCABrooke-WavellKOptimum frequency of exercise for bone health: randomised controlled trial of a high-impact unilateral interventionBone20104641043104920004758
   PubMed Web of Science ®Google Scholar
• FriskJManaging hot flushes in men after prostate cancer – a systematic reviewMaturitas2010651152219962840
   PubMed Web of Science ®Google Scholar